European Partnerships under Horizon Europe
Pick a topic from the menu to get started.
With this webinar NCP Flanders, together with VLAIO and FWO, wants to give you an overview of the complex landscape and constructions of EU-Partnerships.
We will guide you through the different types of partnerships and briefly indicate the modalities.
Agenda
- (1) General introduction on partnerships
- Co-programmed
- Co-funded
- Institutionalised
- Partnerships supported by VLAIO
- (2) Institutionalised
- (3) Co-funded
- (4) Others (EUREKA, Eurostars)
- (5) Partnerships supported by FWO
For more information on the EU partnerships, please have a look at the NCP Flanders website page on partnerships or contact the NCP of the related domain.
The VLAIO supported partnerships can be found through this link
The FWO supported partnerships van be found through this link
Pick a topic from the menu to get started.
Testimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
